DK1044209T3 - Fremgangsmåde till fremstilling af 6-O-methylerythromycin A ved at anvende derivater af 9-hydroxyerythromycin - Google Patents

Fremgangsmåde till fremstilling af 6-O-methylerythromycin A ved at anvende derivater af 9-hydroxyerythromycin

Info

Publication number
DK1044209T3
DK1044209T3 DK98959481T DK98959481T DK1044209T3 DK 1044209 T3 DK1044209 T3 DK 1044209T3 DK 98959481 T DK98959481 T DK 98959481T DK 98959481 T DK98959481 T DK 98959481T DK 1044209 T3 DK1044209 T3 DK 1044209T3
Authority
DK
Denmark
Prior art keywords
erythromycin
hydroxyerythromycin
methylerythromycin
derivatives
preparation
Prior art date
Application number
DK98959481T
Other languages
Danish (da)
English (en)
Inventor
David A Riley
Yi-Yin Ku
Elaine C Lee
Jien-Heh J Tien
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of DK1044209T3 publication Critical patent/DK1044209T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK98959481T 1997-12-16 1998-11-17 Fremgangsmåde till fremstilling af 6-O-methylerythromycin A ved at anvende derivater af 9-hydroxyerythromycin DK1044209T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/991,648 US5892008A (en) 1997-12-16 1997-12-16 Process for the preparation of 6-O-methyl erythromycin a using 9-hydroxy erythromycin derivatives
EP98959481A EP1044209B1 (fr) 1997-12-16 1998-11-17 Procede de preparation de 6-o-methyle erythromycine a utilisant des derives de 9-hydroxy erythromycine
PCT/US1998/024498 WO1999031114A1 (fr) 1997-12-16 1998-11-17 Procede de preparation de 6-o-methyle erythromycine a utilisant des derives de 9-hydroxy erythromycine

Publications (1)

Publication Number Publication Date
DK1044209T3 true DK1044209T3 (da) 2004-11-22

Family

ID=25537423

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98959481T DK1044209T3 (da) 1997-12-16 1998-11-17 Fremgangsmåde till fremstilling af 6-O-methylerythromycin A ved at anvende derivater af 9-hydroxyerythromycin

Country Status (13)

Country Link
US (1) US5892008A (fr)
EP (1) EP1044209B1 (fr)
JP (1) JP2002508385A (fr)
KR (1) KR20010033178A (fr)
AT (1) ATE273988T1 (fr)
AU (1) AU1526999A (fr)
CA (2) CA2315209C (fr)
DE (1) DE69825785T2 (fr)
DK (1) DK1044209T3 (fr)
ES (1) ES2229552T3 (fr)
IL (1) IL136237A0 (fr)
PT (1) PT1044209E (fr)
WO (1) WO1999031114A1 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3054699B2 (ja) * 1998-08-07 2000-06-19 工業技術院長 Ｏ−シリル化含水酸基環状エーテルの製造方法
US6437106B1 (en) 1999-06-24 2002-08-20 Abbott Laboratories Process for preparing 6-o-substituted erythromycin derivatives
KR100336447B1 (ko) * 1999-11-24 2002-05-15 민경윤 클라리스로마이신의 개선된 제조방법
EP1254146B1 (fr) * 1999-12-16 2005-08-24 Teva Pharmaceutical Industries Ltd. Procedes de preparation de polymorphes de clarithromycine et nouveau polymorphe iv
PT1280535E (pt) 2000-01-11 2005-04-29 Teva Pharma Processos para a preparacao de polimorfos de claritromicina
US6565882B2 (en) * 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
CA2401571A1 (fr) * 2000-02-29 2001-09-07 Ilya Avrutov Procedes de preparation de la clarithromycine et d'un intermediaire de la clarithromycine, notamment la clarithromycine exempte d'oxime, et composition pharmaceutique correspondante
US6605707B1 (en) 2000-03-23 2003-08-12 Abbott Laboratories Process for the preparation of 6-O-propargyl erythromycin derivatives
US6541014B2 (en) * 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020068078A1 (en) * 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US20020197314A1 (en) * 2001-02-23 2002-12-26 Rudnic Edward M. Anti-fungal composition
ITMI20021726A1 (it) * 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
EP1648407A4 (fr) 2003-07-21 2011-08-31 Middlebrook Pharmaceuticals Inc Produit antibiotique, utilisation et formulation correspondantes
WO2005009364A2 (fr) * 2003-07-21 2005-02-03 Advancis Pharmaceutical Corporation Produit antibiotique, utilisation et formulation associees
JP2006528189A (ja) * 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質産物、その使用法および製剤
EP1653925A1 (fr) * 2003-08-11 2006-05-10 Advancis Pharmaceutical Corporation Pastille robuste
JP2007502294A (ja) 2003-08-12 2007-02-08 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
EP1658034A4 (fr) * 2003-08-29 2011-06-22 Middlebrook Pharmaceuticals Inc Produit antibiotique, son utilisation et sa formulation
CA2538064C (fr) * 2003-09-15 2013-12-17 Advancis Pharmaceutical Corporation Antibiotique, son utilisation et sa formulation
WO2006014427A1 (fr) * 2004-07-02 2006-02-09 Advancis Pharmaceutical Corporation Comprimé pour distribution par impulsion
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8778924B2 (en) * 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
WO2009023191A2 (fr) * 2007-08-09 2009-02-19 Teva Pharmaceutical Industries Ltd. Procédé amélioré de préparation de la clarithromycine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4331803A (en) * 1980-06-04 1982-05-25 Taisho Pharmaceutical Co., Ltd. Novel erythromycin compounds
JPS61103890A (ja) * 1984-10-26 1986-05-22 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシンａ誘導体
US4670549A (en) * 1985-03-18 1987-06-02 Taisho Pharmaceutical Co., Ltd. Method for selective methylation of erythromycin a derivatives
US4640910A (en) * 1985-11-12 1987-02-03 Abbott Laboratories Erythromycin A silylated compounds and method of use
KR960000434B1 (ko) * 1986-12-17 1996-01-06 다이쇼 세이야꾸 가부시끼가이샤 에리스로마이신 a유도체 및 그의 제조 방법
US5872229A (en) * 1995-11-21 1999-02-16 Abbott Laboratories Process for 6-O-alkylation of erythromycin derivatives

Also Published As

Publication number Publication date
CA2315209A1 (fr) 1999-06-24
JP2002508385A (ja) 2002-03-19
EP1044209B1 (fr) 2004-08-18
ATE273988T1 (de) 2004-09-15
CA2315209C (fr) 2008-04-08
CA2615701A1 (fr) 1999-06-24
DE69825785T2 (de) 2005-08-18
PT1044209E (pt) 2004-11-30
EP1044209A1 (fr) 2000-10-18
KR20010033178A (ko) 2001-04-25
DE69825785D1 (de) 2004-09-23
ES2229552T3 (es) 2005-04-16
US5892008A (en) 1999-04-06
AU1526999A (en) 1999-07-05
IL136237A0 (en) 2001-05-20
WO1999031114A1 (fr) 1999-06-24

Similar Documents

Publication Publication Date Title
DK1044209T3 (da) Fremgangsmåde till fremstilling af 6-O-methylerythromycin A ved at anvende derivater af 9-hydroxyerythromycin
DK0891370T3 (da) 2'-beskyttede 3'-dimethylamin, 9-etheroxim-erythromycin A-derivater
BG103673A (en) 3'-n-oxide, 3'-n-dimethylamine, 9-oxime derivatives of erythromycin a
AR240833A1 (es) Metodo para preparar derivados de 6-o-metil-eritromicina a por metilacion selectiva de derivados 6-hidroxi de eritromicina a.
DE60129553D1 (de) Nukleotidderivate mit einer reportergruppe und einer polymerase-enzym-blockierende gruppe
ATE162796T1 (de) 4-a-substutierte avermectinderivate
MX9801859A (es) Nuevos derivados de 5-o-desosaminil-6-o-metil-eritronolida a, su procedimiento de preparacion y su aplicacion para la preparacion de productos biologicamente activos.
NZ335825A (en) Use of azithromycin for treating atherosclerosis
IL135517A0 (en) Chemical synthesis of 6-0-alkyl erythromycin a
HUP0104600A2 (hu) Új intermedierek és eljárás azokból makrolid antibiotikum előállítására
IE821260L (en) Anthracycline derivatives
ES2079436T3 (es) Clonacion de genes de streptomyces avermitilis para biosintesis de avermectinas y procedimientos para su uso.
DE60019905D1 (de) Oxyalkylen-substituierte aminophenol-derivate
DE3770359D1 (de) 6-amino-anthracycline, verfahren zu ihrer herstellung und ihre verwendung.
IL159004A0 (en) An arylation method for the functionalization of o-allyl erythromycin derivatives
BG106123A (en) Diphosphate salt of a 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin derivative and its pharmaceutical composition
PT88952A (pt) Processo para a preparacao de avermectinas etiladas
DE69329821D1 (de) Ein streptomyces avermitilis-stamm glykosyliert avermectin-verbindungen
EP0311694A4 (en) Nucleoside derivatives and process for their preparation
BG103726A (en) New hydroxyderivatives of tylosin and method for their preparation
ES8700268A1 (es) Un procedimiento para la preparacion de compuestos de eritromicina 6-0, 11-0, 6-11-di-0-alquilados.
WO1999032500A3 (fr) Intermediaires utilises dans la production de macrolides
AU2002318856A1 (en) Vaginal Suppository Vaccine for Urogenital Infections